GlaxoSmithKline Pharmaceuticals (India) Today
| GLAXO Stock | 2,342 70.15 2.91% |
Performance0 of 100
| Odds Of DistressLess than 10
|
GlaxoSmithKline Pharmaceuticals is selling at 2341.65 as of the 26th of November 2024; that is 2.91 percent decrease since the beginning of the trading day. The stock's open price was 2411.8. GlaxoSmithKline Pharmaceuticals has less than a 10 % chance of experiencing some financial distress in the next two years of operation, but has generated negative returns over the last 90 days. Equity ratings for GlaxoSmithKline Pharmaceuticals Limited are calculated daily based on our scoring framework. The performance scores are derived for the period starting the 7th of December 2022 and ending today, the 26th of November 2024. Click here to learn more.
Business Domain Pharmaceuticals, Biotechnology & Life Sciences | Category Healthcare | Classification Health Care |
GlaxoSmithKline Pharmaceuticals is entity of India. It is traded as Stock on NSE exchange. The company has 169.41 M outstanding shares. More on GlaxoSmithKline Pharmaceuticals Limited
Follow Valuation Profit Patterns Odds of Bankruptcy
Check how we calculate scores
GlaxoSmithKline Stock Highlights
Most reasonable investors view market volatility as an opportunity to invest at a favorable price or to sell short against a bearish trend. GlaxoSmithKline Pharmaceuticals' investment highlights are automatically generated signals that are significant enough to either complement your investing judgment regarding GlaxoSmithKline Pharmaceuticals or challenge it. These highlights can help you better understand the position you are entering and avoid costly mistakes.
| Business Concentration | Pharmaceuticals, Pharmaceuticals, Biotechnology & Life Sciences, Health Care, Health Care, Pharmaceuticals, Drug Manufacturers-General, Healthcare (View all Sectors) |
GlaxoSmithKline Pharmaceuticals Limited (GLAXO) is traded on National Stock Exchange of India in India and employs 3,211 people. GlaxoSmithKline Pharmaceuticals is listed under Pharmaceuticals category by Fama And French industry classification. The company currently falls under 'Mega-Cap' category with a current market capitalization of 409.15 B. Market capitalization usually refers to the total value of a company's stock within the entire market. To calculate GlaxoSmithKline Pharmaceuticals's market, we take the total number of its shares issued and multiply it by GlaxoSmithKline Pharmaceuticals's current market price. To manage market risk and economic uncertainty, many investors today build portfolios that are diversified across equities with different market capitalizations. However, as a general rule, conservative investors tend to hold large-cap stocks, and those looking for more risk prefer small-cap and mid-cap equities. GlaxoSmithKline Pharmaceuticals operates under Pharmaceuticals sector and is part of Health Care industry. The entity has 169.41 M outstanding shares.
GlaxoSmithKline Pharmaceuticals generates positive cash flow from operations, but has no cash available
Check GlaxoSmithKline Pharmaceuticals Probability Of Bankruptcy
Ownership AllocationGlaxoSmithKline Pharmaceuticals Limited has a total of 169.41 Million outstanding shares. GlaxoSmithKline Pharmaceuticals retains majority of its outstanding shares owned by insiders. An insider is usually defined as a corporate executive, director, member of the board or institutional investor who own at least 10% of the company's outstanding shares. 75.58 (percent) of GlaxoSmithKline Pharmaceuticals outstanding shares that are owned by insiders attests that they have been buying or selling the stock in recent months in anticipation of some upcoming event. Please note that no matter how many assets the company holds, if the real value of the firm is less than the current market value, you may not be able to make money on it.
Check GlaxoSmithKline Ownership Details
GlaxoSmithKline Pharmaceuticals Risk Profiles
Although GlaxoSmithKline Pharmaceuticals' alpha and beta are two of the key measurements used to evaluate GlaxoSmithKline Pharmaceuticals' performance over the market, the standard measures of volatility play an important role as well.
| Mean Deviation | 1.38 | |||
| Standard Deviation | 1.79 | |||
| Variance | 3.19 | |||
| Risk Adjusted Performance | (0.14) |
GlaxoSmithKline Stock Against Markets
Be your own money manager
Our tools can tell you how much better you can do entering a position in GlaxoSmithKline Pharmaceuticals without increasing your portfolio risk or giving up the expected return. As an individual investor, you need to find a reliable way to track all your investment portfolios. However, your requirements will often be based on how much of the process you decide to do yourself. In addition to allowing all investors analytical transparency into all their portfolios, our tools can evaluate risk-adjusted returns of your individual positions relative to your overall portfolio.Did you try this?
Run Earnings Calls Now
Earnings CallsCheck upcoming earnings announcements updated hourly across public exchanges |
| All Next | Launch Module |
GlaxoSmithKline Pharmaceuticals Corporate Management
Elected by the shareholders, the GlaxoSmithKline Pharmaceuticals' board of directors comprises two types of representatives: GlaxoSmithKline Pharmaceuticals inside directors who are chosen from within the company, and outside directors, selected externally and held independent of GlaxoSmithKline. The board's role is to monitor GlaxoSmithKline Pharmaceuticals' management team and ensure that shareholders' interests are well served. GlaxoSmithKline Pharmaceuticals' inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, GlaxoSmithKline Pharmaceuticals' outside directors are responsible for providing unbiased perspectives on the board's policies.
| Abhinav Kashyap | VP Technology | Profile | |
| Ajay Nadkarni | VP Secretary | Profile | |
| Amit Pandey | Executive Legal | Profile | |
| Chinmay Sharma | Executive Resources | Profile | |
| Rashmi MD | Executive Medical | Profile | |
| Ransom DSouza | Executive Affairs | Profile | |
| Simrat Sohal | Vice Compliance | Profile |
Other Information on Investing in GlaxoSmithKline Stock
GlaxoSmithKline Pharmaceuticals financial ratios help investors to determine whether GlaxoSmithKline Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in GlaxoSmithKline with respect to the benefits of owning GlaxoSmithKline Pharmaceuticals security.